SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Filing Date
Feb 4, 2019
Document Date
Feb 4, 2019
Form Description
An amendment to the SC 13G filing
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.